Market Intelligence chevron_right Medical Devices & Consumables chevron_right Recombinant Carboxypeptidase B
Global Report 2025

Global Recombinant Carboxypeptidase B Market Growth 2025-2031

calendar_todayPublished: May 2025 descriptionPages: 124 categoryCategory: Medical Devices & Consumables
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

The global Recombinant Carboxypeptidase B market size is predicted to grow from US$ 547 million in 2025 to US$ 956 million in 2031; it is expected to grow at a CAGR of 9.8% from 2025 to 2031.

Recombinant carboxypeptidase B is an enzyme obtained through genetic engineering technology. The gene of recombinant carboxypeptidase B usually comes from organisms in nature, such as Escherichia coli or Pichia pastoris. Through cloning, expression and purification, the recombinant carboxypeptidase B is separated and purified from recombinant Pichia pastoris or Escherichia coli, and then freeze-dried to obtain the lyophilized powder of recombinant carboxypeptidase B.

Key Features

Recombinant carboxypeptidase B belongs to the metallocarboxypeptidase family, and each molecule contains one Zn atom. It has the ability to specifically hydrolyze the amino end of the C-terminal basic amino acids of proteins (such as lysine, arginine, and histidine). This characteristic makes it have a wide range of application potential in protein sequence analysis, modification, and peptide synthesis.

Segmentation by Type

  • >90%
  • >95%
  • Others

Segmentation by Application

  • Functional Studies
  • SDS-PAGE
  • HPLC
  • Others

Market by Region

Americas:

  • United States
  • Canada
  • Mexico
  • Brazil

APAC:

  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia

Europe:

  • Germany
  • France
  • UK
  • Italy
  • Russia

Middle East & Africa:

  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Company's Coverage

  • Roche
  • PeproTech
  • Prospec Bio
  • BPS Bioscience
  • Shanghai Yaxin Biotechnology Co., Ltd.
  • R&D Systems
  • RayBiotech
  • Abcam
  • Advent Bio
  • Innovative Research
  • enQuire BioReagents
  • Lonza Bioscience
  • Boster Bio
  • ProSci

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Recombinant Carboxypeptidase B market?
  • What factors are driving Recombinant Carboxypeptidase B market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Recombinant Carboxypeptidase B market opportunities vary by end market size?
  • How does Recombinant Carboxypeptidase B break out by Type, by Application?

Frequently Asked Questions

What is the USP of the report? expand_more
Recombinant Carboxypeptidase B report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Recombinant Carboxypeptidase B report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Recombinant Carboxypeptidase B report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.